Five-Year Sales for Newly Marketed Prescription Drugs With and Without Initial Orphan Drug Act Designation

This study evaluates sales revenue earned in the first 5 years for newly marketed brand-name drugs with and without an initial orphan drug designation.

Automated summary

This study assesses the sales revenue generated in the first five years for newly launched brand-name drugs, comparing those with and without an initial orphan drug designation.